Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60.4M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
11.1M
-
Shares change
-
-3.72M
-
Total reported value, excl. options
-
$12.4M
-
Value change
-
-$4.46M
-
Put/Call ratio
-
0.82
-
Number of buys
-
18
-
Number of sells
-
-38
-
Price
-
$1.12
Significant Holders of Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) as of Q2 2022
66 filings reported holding AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share as of Q2 2022.
Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.1M shares
of 60.4M outstanding shares and own 18.42% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2.65M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.65M shares), Capital World Investors (1.6M shares), VANGUARD GROUP INC (671K shares), Kamunting Street Capital Management, L.P. (581K shares), GSA CAPITAL PARTNERS LLP (372K shares), AMERICAN FINANCIAL GROUP INC (300K shares), RENAISSANCE TECHNOLOGIES LLC (262K shares), HighTower Advisors, LLC (250K shares), and BlackRock Inc. (227K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.